Gulshan Rathore

Gulshan Rathore

Auto-generated profile, based on publicly available information

Gulshan Rathore

Department of Pharmaceutics, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2025 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
AKAvnish Kumar
Avnish Kumar
AVAnurag Verma
Anurag Verma
GRGulshan Rathore
Gulshan Rathore
A major barrier to effective therapy is the limited water solubility of many Biopharmaceutics Classification System (BCS) Class II and IV medications, which results in poor bioavailability and inconsistent patient outcomes. Better solubilization and stability are provided by traditional synthetic nanocarriers such as PLGA, poloxamers, and PEG-PLA; however, these have disadvantages such as toxicity, cost, reliance on petrochemical resources, and regulatory barriers. Natural amphiphilic co-polymers (NACPs) are a sustainable and amiable alternative to proteins, polysaccharides, and phospholipids. Because of their innate amphiphilicity, which promotes self-assembly into micelles, vesicles, nanogels, and hydrogels, hydrophobic drugs can be effectively encapsulated and released under controlled conditions.This review focuses on the structural foundations of amphiphilicity in graft and block copolymers, naturally occurring self-assembling systems, and chemically modified derivatives that enhance solubility and drug-polymer interactions. In contrast to synthetic carriers, NACPs have other benefits such as mucoadhesion, enzymatic degradability, pH/enzyme responsiveness, and generally recognized as safe (GRAS) regulatory status, even though problems with scalability, reproducibility, and long-term stability still exist. Their versatility includes oral, parenteral, transdermal, pulmonary, nasal, and ocular drug delivery, with notable improvements in solubility, bioavailability, and therapeutic accuracy. Recent advancements include stimuli-responsive designs, hybrid natural-synthetic systems, and artificial intelligence (AI)-driven modeling for predicting drug-polymer compatibility. Collectively, NACPs present a sustainable strategy for next-generation nanomedicine that strikes a balance between therapeutic efficacy and environmental responsibility. By addressing solubility concerns with environmentally acceptable carriers, NACPs have a substantial translational potential to promote pharmaceutical innovation and green drug delivery systems.


10 June 2026 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
GRGulshan Rathore
Gulshan Rathore
RSRavindra Pal Singh
Ravindra Pal Singh

5 October 2026 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
AKAvnish Kumar
Avnish Kumar
GRGulshan Rathore
Gulshan Rathore
AVAnurag Verma
Anurag Verma
1. Compared to previously described natural nanocarrier platforms, the majority of prior approaches have used a mixture of natural components alone, for example, lecithin-only liposomes, chitosan- ...

23 May 2026 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
GRGulshan Rathore
Gulshan Rathore
RSRavindra pal Singh
Ravindra pal Singh
1. Type 2 diabetes mellitus (T2DM) represents a multifactorial metabolic disorder characterized by progressive β-cell dysfunction, peripheral insulin resistance, and dysregulated hepatic glucose ou...

1 December 2025 in Journal of Dermatologic Science and Cosmetic Technology
Verified
Journal Article
Open access
MSMohammad Shavez
Mohammad Shavez
AVAnurag Verma
Anurag Verma
GRGulshan Rathore
Gulshan Rathore